What are Microbot Medical's total assets?

Microbot Medical (MBOT) holds $78.1M in total assets, up 152.7% year over year.

How much debt does Microbot Medical have?

Microbot Medical carries $898.0K in total debt against $74.1M of shareholders' equity, a debt-to-equity ratio of 0.01.

How much cash does Microbot Medical have?

Microbot Medical holds $3.7M in cash and equivalents.

Can Microbot Medical cover its short-term obligations?

Its current ratio is 22.59 — current assets exceed current liabilities.

Where does Microbot Medical's balance sheet data come from?

Every line is extracted from Microbot Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Microbot Medical MBOT Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$3.91M+25.6%	$3.11M+26.2%	$2.47M+1.1%	$2.44M-81.9%
Short-term investments	$74.68M+3,070%	$2.36M-39.9%	$3.92M-32.0%	$5.76M+188%
Restricted cash	$2K-95.9%	$49K0.0%	$49K-36.4%	$77K-11.5%
Accounts receivable, net	——	——	——	——
Inventories	$1.02M—	——	——	——
Raw materials	$416K—	——	——	——
Work in process	$168K—	——	——	——
Prepaid expenses and other current assets	$644K+115%	$300K+97.4%	$152K-71.4%	$532K+77.3%
Total current assets	$79.82M+1,272%	$5.82M-26.5%	$7.92M-10.1%	$8.81M-44.5%
Property and equipment, net	$93K+16.3%	$80K-45.2%	$146K-33.9%	$221K-9.4%
Operating lease right-of-use assets	8.2%+1.5%	6.7%-0.3%	7%-2.0%	9%0.0%
Other non-current assets	$737K—	——	——	——
Total assets	$81.54M+1,252%	$6.03M-27.6%	$8.33M-12.7%	$9.54M-43.1%
Accounts payable	$511K+210%	$165K-53.8%	$357K+208%	$116K-58.4%
Accrued expenses	$2.61M+85.5%	$1.41M+94.3%	$725K-47.2%	$1.37M+33.1%
Operating lease liabilities, current	$296K+323%	$70K-63.4%	$191K-32.5%	$283K+1.8%
Total current liabilities	$3.42M+39.1%	$2.46M-35.0%	$3.79M+83.0%	$2.07M+4.3%
Operating lease liabilities, non-current	$569K+1,288%	$41K+2.5%	$40K-77.7%	$179K-55.5%
Operating Lease Liabilities (Total)	$865K+679%	$111K-51.9%	$231K-50.0%	$462K-32.1%
Total liabilities	$3.99M+59.5%	$2.5M-34.6%	$3.83M+70.2%	$2.25M-5.8%
Common stock	120M+100%	60M0.0%	60M0.0%	60M0.0%
Additional paid-in capital	$180.97M+91.9%	$94.28M+12.4%	$83.88M+10.4%	$75.97M+8.7%
Retained earnings	-$104.09M-14.5%	-$90.94M-14.4%	-$79.5M-15.6%	-$68.76M-23.7%
Total stockholders' equity	$77.55M+2,097%	$3.53M-21.6%	$4.5M-38.2%	$7.29M-49.3%
Total liabilities and stockholders' equity	$81.54M+1,252%	$6.03M-27.6%	$8.33M-12.7%	$9.54M-43.1%
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)	$3.97M+25.6%	$3.16M+25.7%	$2.52M-0.1%	$2.52M-81.5%
Cash Cash Equivalents And Short Term Investments	$78.59M+1,337%	$5.47M-14.3%	$6.39M-22.2%	$8.2M-47.1%
Short- term Investments	$74.68M+3,070%	$2.36M-39.9%	$3.92M-32.0%	$5.76M+188%
Customer Collateral Assets	——	——	——	$3K—
Raw materials and supplies inventory, gross	$416K—	——	——	——
Deposits on Licenses	$737K—	——	——	——
Net Investment in Lease	$833K+531%	$132K-49.2%	$260K-48.2%	$502K-22.0%
Operating lease right-of-use assets	$833K+531%	$132K-49.2%	$260K-48.2%	$502K-22.0%
Operating Lease Right-of-Use Assets in Other Assets	$833K+531%	$132K-49.2%	$260K-48.2%	$502K-22.0%
Other Commercial Liabilities	$2.61M+17.5%	$2.23M+117%	$1.03M-38.5%	$1.67M+17.0%
Accrued Liabilities, Current	$2.61M+17.5%	$2.23M+117%	$1.03M-38.5%	$1.67M+17.0%
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	$256K+510%	$42K-12.5%	$48K-73.5%	$181K-32.7%
Operating Lease Liability Payments - 2025 (Lessee)	$196K+367%	$42K-12.5%	$48K-73.5%	$181K-32.7%
Lease Liability Payments - Due Year Two	$256K+510%	$42K-12.5%	$48K-73.5%	$181K-32.7%
Lease Liability Payments - Due Year Three	$238K—	——	$21K+950%	$2K-98.8%
Lease Liability Payments - Remainder of Fiscal Year	$308K+311%	$75K-63.9%	$208K-33.3%	$312K—
Operating Lease Liability Payments Due	$998K+753%	$117K-57.8%	$277K-44.0%	$495K-34.5%
Operating Lease Liability - Undiscounted Excess Amount	$133K+2,117%	$6K-87.2%	$47K+42.4%	$33K-56.6%
Operating Lease Liability Payments - 2027 (Lessee)	$238K—	——	$21K+950%	$2K-98.8%
Total debt	$865K+679%	$111K-51.9%	$231K-50.0%	$462K-32.1%
Common Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common Stock Shares Authorized	——	2.5M+19.2%	2.1M+39.0%	1.5M+51.1%
Common Stock Shares Issued	67.2M+246%	19.4M+65.7%	11.7M+48.4%	7.9M+11.0%
Convertible Preferred Stock Authorized Shares	——	——	——	——
Additional paid-in capital	$180.97M+91.9%	$94.28M+12.4%	$83.88M+10.4%	$75.97M+8.7%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$672K+245%	$195K+65.3%	$118K+47.5%	$80K+11.1%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	$1.11M+20.4%	$921K-52.0%	$1.92M-5.8%	$2.04M—
Warrants and Rights Outstanding	16.3M+214%	5.2M—	——	——
Capital Units Authorized	——	——	——	——
Cash and cash equivalents, end of period	$3.97M+25.6%	$3.16M+25.7%	$2.52M-0.1%	$2.52M-81.5%
Class of Warrant or Right, Outstanding	$16.31M+214%	$5.19M—	——	——
Common stock, par value (in dollars per share)	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	$120M+100%	$60M0.0%	$60M0.0%	$60M0.0%
Common stock, shares issued (in shares)	$67.16M+246%	$19.4M+65.7%	$11.71M+48.4%	$7.89M+11.0%
Common Stock, Shares, Outstanding	$67.16M+246%	$19.4M+65.7%	$11.71M+48.4%	$7.89M+11.0%
Deferred Income	$93K—	——	——	——
Deferred Tax Assets Accrued Vacation Pay	$101K+46.4%	$69K+16.9%	$59K-16.9%	$71K+57.8%
Deferred Tax Assets Advance Payment From Iia	$22K—	——	$17K—	——
Deferred Tax Assets, Net of Valuation Allowance	$191K+537%	$30K-91.6%	$357K+213%	$114K-23.0%
Deferred Tax Assets Operation Lease Liabilities	$198K+662%	$26K-50.9%	$53K-49.5%	$105K-32.7%
Deferred Tax Liabilities, Net	$191K+537%	$30K-91.6%	$357K+213%	$114K-23.0%
Deferred Tax Liabilities Operating Leases Rightof Use Assets	$191K+537%	$30K-50.0%	$60K-47.4%	$114K-23.0%
Deposit Assets	$737K—	——	——	——
Unrecognized compensation cost related to non-vested awards	$1.11M+20.4%	$921K-52.0%	$1.92M-5.8%	$2.04M—
Inducement Transaction Cost	$2.47K—	——	——	——
Lessee Operating Lease Liability Payments Due	$998K+753%	$117K-57.8%	$277K-44.0%	$495K-34.5%
Lessee Operating Lease Liability Undiscounted Excess Amount	$133K+2,117%	$6K-87.2%	$47K+42.4%	$33K-56.6%
Long Lived Assets And Operating Lease Right Of Use Assets	$926K+337%	$212K-47.8%	$406K—	——
Operating Lease Weighted Average Discount Rate Percent	$0.08+22.4%	$0.07-4.3%	$0.07-22.2%	$0.090.0%
Preferred Stock, Shares Authorized	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price	$1.65+66.7%	$0.99-29.3%	$1.40-68.9%	$4.50—
Unpaid Amount	$101—	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Microbot Medical.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Microbot Medical's total assets?: Microbot Medical (MBOT) holds $78.1M in total assets, up 152.7% year over year.
How much debt does Microbot Medical have?: Microbot Medical carries $898.0K in total debt against $74.1M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does Microbot Medical have?: Microbot Medical holds $3.7M in cash and equivalents.
Can Microbot Medical cover its short-term obligations?: Its current ratio is 22.59 — current assets exceed current liabilities.
Where does Microbot Medical's balance sheet data come from?: Every line is extracted from Microbot Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.